Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

EBT Share Purchase

23 May 2018 10:27

RNS Number : 0236P
Cenkos Securities PLC
23 May 2018
 

23 May 2018

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

EBT Share Purchase

 

The Company was notified on 22 May 2018 that, in accordance with the trading plan between the Company and Zedra Trust Company (Guernsey) Limited ( the "Trustee") announced on 23 May 2017, the Cenkos Securities plc Employee Benefit Trust (the "EBT") purchased 44,910 ordinary shares in the Company at a price of £1.11 per ordinary share on 21 May 2018. These ordinary shares are to be held in the EBT and are intended to be used to satisfy current and future share awards made under the Company's employee incentive and share option awards. The EBT is a discretionary trust for the benefit of the Company's employees, including the executive directors of the Company.

 

Following this transaction, a total of 160,118 Ordinary Shares are held, unallocated, by the Company's employee benefit trusts.

 

 

 

Enquiries:

 

Anthony Hotson +44 20 7397 8900

Chief Executive Officer

Cenkos Securities plc

 

Dr Azhic Basirov / David Jones / Ben Jeynes +44 20 7131 4000

Nominated Adviser

Smith & Williamson Corporate Finance Limited

 

Nick Lovering +44 20 7659 1224

Joint Broker

Whitman Howard Limited

 

David Rydell +44 20 7466 5066

Buchanan Communications

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSKXLBLVEFLBBE

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.